Robert Barrow - Chief Executive Officer, Director at Definium Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Issuer Symbol
DFTX on Nasdaq
All Insider Reports
All Insider Reports

Robert Barrow - trading volume in the past year for Definium Therapeutics, Inc.

Holdings reported by Robert Barrow for Definium Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Shares 1,098,477 $14,708,826 $13.39 03 Feb 2026 Direct

Transactions reported by Robert Barrow for Definium Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.